Indexed keywords
2 AMINO 6 METHYL 5 [(2' PYRIMIDINY)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (1' METHYLIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (5' BROMOBENZIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (5' CHLOROBENZIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (5' METHYLBENZIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (5' NITROBENZIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (5' PHENYL 1',3',4' OXADIZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (BENZIMIDAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (BENZOTHIAZOLYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 D]PYRIMIDINE;
2 AMINO 6 METHYL 5 [2' (PYRIMIDINYL)SULFANYL] 3,4 DIHYDRO 4 OXO 7H PYRROLO [2,3 I]PYRIMIDINE;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE;
BENZOTHIAZOLE;
FLUOROURACIL;
PYRROLO[2,3 B]PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
COLON CANCER;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
APOPTOSIS;
COLONIC NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HCT116 CELLS;
HUMANS;
INHIBITORY CONCENTRATION 50;
MAGNETIC RESONANCE SPECTROSCOPY;
PYRIMIDINES;
PYRROLES;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
5
0025997350
ICID 1694
Jackman A.L., Taylor G.A., Gibson W., Kimbell R., Brown M., Calvert A.H., Judson I.R., and Hughes L. ICID 1694. Cancer Res. 51 (1991) 5579-5586
(1991)
Cancer Res.
, vol.51
, pp. 5579-5586
Jackman, A.L.1
Taylor, G.A.2
Gibson, W.3
Kimbell, R.4
Brown, M.5
Calvert, A.H.6
Judson, I.R.7
Hughes, L.8
6
0026494947
Taylor E.C., Kuhnt D., Shih C., Rinzel S.M., Grindey G.B., Barredo J., Jannatipour M., and Moran R. J. Med. Chem. 35 (1992) 4450-4454
(1992)
J. Med. Chem.
, vol.35
, pp. 4450-4454
Taylor, E.C.1
Kuhnt, D.2
Shih, C.3
Rinzel, S.M.4
Grindey, G.B.5
Barredo, J.6
Jannatipour, M.7
Moran, R.8
7
0027403420
Webber S.E., Bleckman T.M., Attard J., Deal J.G., Katherdekar V., Welsh K.M., Webber S., Janson C.A., Matthews D.A., Smith W.W., freer S.T., Jordan S.R., Bacquet R.J., Howland E.F., Booth C.J.L., Ward R.W., Hermann S.M., White J., Morse C.A., Hilliard J.A., and Bartlett C.A. J. Med. Chem. 36 (1993) 733-746
(1993)
J. Med. Chem.
, vol.36
, pp. 733-746
Webber, S.E.1
Bleckman, T.M.2
Attard, J.3
Deal, J.G.4
Katherdekar, V.5
Welsh, K.M.6
Webber, S.7
Janson, C.A.8
Matthews, D.A.9
Smith, W.W.10
freer, S.T.11
Jordan, S.R.12
Bacquet, R.J.13
Howland, E.F.14
Booth, C.J.L.15
Ward, R.W.16
Hermann, S.M.17
White, J.18
Morse, C.A.19
Hilliard, J.A.20
Bartlett, C.A.21
more..
8
9044239673
Webber S., Bartlett C.A., Boritzki T.J., Hilliard J.A., Howland E.F., Johnston A.L., Kosa M., Margosiak C.A., Morse S.A., and Shetty B.V. Cancer Chemother. Pharmacol. 37 (1996) 509-517
(1996)
Cancer Chemother. Pharmacol.
, vol.37
, pp. 509-517
Webber, S.1
Bartlett, C.A.2
Boritzki, T.J.3
Hilliard, J.A.4
Howland, E.F.5
Johnston, A.L.6
Kosa, M.7
Margosiak, C.A.8
Morse, S.A.9
Shetty, B.V.10
9
0033598331
Marsham P.R., Wardleworth J.M., Boyle F.T., Hennequin L.F., Kimbell R., Brown M., and Jackmann A.L. J. Med. Chem. 42 (1999) 3809-3820
(1999)
J. Med. Chem.
, vol.42
, pp. 3809-3820
Marsham, P.R.1
Wardleworth, J.M.2
Boyle, F.T.3
Hennequin, L.F.4
Kimbell, R.5
Brown, M.6
Jackmann, A.L.7
10
0031907650
Creaven P.J., Pendyala L., Meropol N.J., Clendeninn N.J., Wu E.Y., Lowen G.M., Proefrock A., Johnson A., and Dixon M. Cancer Chemother. Pharmacol. 41 (1998) 167-170
(1998)
Cancer Chemother. Pharmacol.
, vol.41
, pp. 167-170
Creaven, P.J.1
Pendyala, L.2
Meropol, N.J.3
Clendeninn, N.J.4
Wu, E.Y.5
Lowen, G.M.6
Proefrock, A.7
Johnson, A.8
Dixon, M.9
15
0036021202
Hao D., Rizzo J.D., Stringer S., Moore R.V., Marty J., Dexter D.L., Mangold G.L., Camden B.J., Daniel D., and Weitman V.H.S.D. Invest. New Drugs 20 (2002) 261-270
(2002)
Invest. New Drugs
, vol.20
, pp. 261-270
Hao, D.1
Rizzo, J.D.2
Stringer, S.3
Moore, R.V.4
Marty, J.5
Dexter, D.L.6
Mangold, G.L.7
Camden, B.J.8
Daniel, D.9
Weitman, V.H.S.D.10
16
0037325622
Hutchinson I., Bradshaw T.D., Matthews C.S., Stevens M.F.G., and Westwell A.D. Biorg. Med. Chem. Lett. 13 (2003) 471-474
(2003)
Biorg. Med. Chem. Lett.
, vol.13
, pp. 471-474
Hutchinson, I.1
Bradshaw, T.D.2
Matthews, C.S.3
Stevens, M.F.G.4
Westwell, A.D.5
17
0031933503
Bradshaw T.D., Wrigley S., Shi D.F., Schutz R.J., Paull K.D., and Stevens M.F. Br. J. Cancer 77 (1998) 745-752
(1998)
Br. J. Cancer
, vol.77
, pp. 745-752
Bradshaw, T.D.1
Wrigley, S.2
Shi, D.F.3
Schutz, R.J.4
Paull, K.D.5
Stevens, M.F.6
18
0029780539
Shi D.F., Bradshaw T.D., Wrigley S., Mc Call C.J., Lelieveld P., Fichtner I., and Stevens M.F.G. J. Med. Chem. 39 (1996) 3375-3384
(1996)
J. Med. Chem.
, vol.39
, pp. 3375-3384
Shi, D.F.1
Bradshaw, T.D.2
Wrigley, S.3
Mc Call, C.J.4
Lelieveld, P.5
Fichtner, I.6
Stevens, M.F.G.7
19
20644449686
Yoshida M., Hayakawa I., Hayashi N., Agatsuma T., Oda Y., Tanzawa F., Iwasaki S., Koyama K., Furukawa H., Kurakata S., and Sugano Y. Bioorg. Med. Chem. Lett. 15 (2005) 3328-3332
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 3328-3332
Yoshida, M.1
Hayakawa, I.2
Hayashi, N.3
Agatsuma, T.4
Oda, Y.5
Tanzawa, F.6
Iwasaki, S.7
Koyama, K.8
Furukawa, H.9
Kurakata, S.10
Sugano, Y.11
20
0029804033
Gangjee A., Mavandadi F., Kisluik R.L., Mc Guire J.J., and Queener S.F. J. Med. Chem. 39 (1996) 4563-4568
(1996)
J. Med. Chem.
, vol.39
, pp. 4563-4568
Gangjee, A.1
Mavandadi, F.2
Kisluik, R.L.3
Mc Guire, J.J.4
Queener, S.F.5
22
38349188175
Janakiram N.B., Indraine C., Altaf M., Steele V.E., and Rao C.V. Mol. Cancer Ther. 7 (2008) 181-190
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 181-190
Janakiram, N.B.1
Indraine, C.2
Altaf, M.3
Steele, V.E.4
Rao, C.V.5